These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27459325)

  • 1. A redox-sensitive, oligopeptide-guided, self-assembling, and efficiency-enhanced (ROSE) system for functional delivery of microRNA therapeutics for treatment of hepatocellular carcinoma.
    Hu Q; Wang K; Sun X; Li Y; Fu Q; Liang T; Tang G
    Biomaterials; 2016 Oct; 104():192-200. PubMed ID: 27459325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Tumor Suppressor MiR-34a Loaded on ZSM-5 Nanozeolite in Hepatocellular Carcinoma: In Vitro and In Vivo Approach.
    Salah Z; Abd El Azeem EM; Youssef HF; Gamal-Eldeen AM; Farrag AR; El-Meliegy E; Soliman B; Elhefnawi M
    Curr Gene Ther; 2019; 19(5):342-354. PubMed ID: 31701846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-triggered personalized microRNA cocktail therapy for hepatocellular carcinoma.
    Shao S; Hu Q; Wu W; Wang M; Huang J; Zhao X; Tang G; Liang T
    Biomater Sci; 2020 Dec; 8(23):6579-6591. PubMed ID: 33231584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
    Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
    J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
    Technol Cancer Res Treat; ; . PubMed ID: 23862748
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 7.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.